1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Genetic Control of Programmed Cell Death in C. Elegans"}],["$","meta","1",{"name":"description","content":"Dr. Horvitz received the Nobel Prize in Physiology or Medicine in 2002. He is the David Koch Professor of Biology at MIT; an Investigator of Howard Hughes Medical Institute; Neurobiologist (Neurology) and Geneticist (Medicine) at Massachusetts General Hospital; and Member of the McGovern Institute for Brain Research and MIT Center for Cancer Research. He has served on many editorial boards, visiting committees and advisory committees. He has been a consultant to a number of pharmaceuticals and was cofounder of the biotechnology companies NemaPharm, Inc. and Idun Pharmaceuticals. He received an Honorary M.D. from the University of Rome (2004), and Honarary D.Sc. from Cambridge University (2004) and an Honorary D.Sc. from Pennsylvania State University (2006). \n
\n
\nhttp://mit.edu/biology/www/facultyareas/facresearch/horvitz.shtml\n
\n
\nNeuroscience Seminar\n
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Genetic Control of Programmed Cell Death in C. Elegans"}],["$","meta","4",{"property":"og:description","content":"Dr. Horvitz received the Nobel Prize in Physiology or Medicine in 2002. He is the David Koch Professor of Biology at MIT; an Investigator of Howard Hughes Medical Institute; Neurobiologist (Neurology) and Geneticist (Medicine) at Massachusetts General Hospital; and Member of the McGovern Institute for Brain Research and MIT Center for Cancer Research. He has served on many editorial boards, visiting committees and advisory committees. He has been a consultant to a number of pharmaceuticals and was cofounder of the biotechnology companies NemaPharm, Inc. and Idun Pharmaceuticals. He received an Honorary M.D. from the University of Rome (2004), and Honarary D.Sc. from Cambridge University (2004) and an Honorary D.Sc. from Pennsylvania State University (2006). \n
\n
\nhttp://mit.edu/biology/www/facultyareas/facresearch/horvitz.shtml\n
\n
\nNeuroscience Seminar\n
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/99ea9f9c-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/31c96fbc-4bc2-4876-a469-b70a32164246.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Genetic Control of Programmed Cell Death in C. Elegans"}],["$","meta","11",{"name":"twitter:description","content":"Dr. Horvitz received the Nobel Prize in Physiology or Medicine in 2002. He is the David Koch Professor of Biology at MIT; an Investigator of Howard Hughes Medical Institute; Neurobiologist (Neurology) and Geneticist (Medicine) at Massachusetts General Hospital; and Member of the McGovern Institute for Brain Research and MIT Center for Cancer Research. He has served on many editorial boards, visiting committees and advisory committees. He has been a consultant to a number of pharmaceuticals and was cofounder of the biotechnology companies NemaPharm, Inc. and Idun Pharmaceuticals. He received an Honorary M.D. from the University of Rome (2004), and Honarary D.Sc. from Cambridge University (2004) and an Honorary D.Sc. from Pennsylvania State University (2006). \n
\n
\nhttp://mit.edu/biology/www/facultyareas/facresearch/horvitz.shtml\n
\n
\nNeuroscience Seminar\n
"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}